x
Breaking News
0

Valeant Pharmaceuticals International Inc (VRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Valeant Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
17.08 +1.28    +8.10%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
17.05
-0.03
-0.18%
19:58:35 - Real-time Data
Type: Equity
Market: United States
ISIN: CA91911K1021 
CUSIP: 91911K102
  • Volume: 56,838,616
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 16.05 - 17.44
START TRADING NOW
Valeant Pharmaceuticals 17.08 +1.28 +8.10%

VRX Overview

 
Information about the Valeant Pharmaceuticals International Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close15.8
Day's Range16.05 - 17.44
Revenue9.41B
Open16.15
52 wk Range8.31 - 32.74
EPS - 4.04
Volume56,838,616
Market Cap5.38B
Dividend (Yield)0 (N/A)
Average Volume (3m)22,708,486
P/E RatioN/A
Beta - 0.3
1-Year Change - 15.74%
Shares Outstanding341,190,987
Next Earnings DateAug 08, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Neutral Buy Buy Buy Sell
Technical Indicators Strong Sell BUY Strong Buy BUY Strong Sell
Summary Sell Buy Strong Buy Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Down 15 Current
Completed Patterns
Bullish Engulfing 1M 1 May 17
Engulfing Bearish 15 1 Jun 26, 2017 15:30
Three Black Crows 1W 4 May 28, 2017

Valeant Pharmaceuticals International Inc News & Analysis

Valeant Pharmaceuticals International Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 17.08 0.00 0.00 56,838,616 +8.10% USD 15:59:59  
  Toronto 22.61 22.61 22.65 3,513,999 +8.03% CAD 16:00:00  
  Mexico 304.83 305.04 311.99 301,883 +6.73% MXN 15:59:00  
  Switzerland 15.190 0.000 0.000 1,600 +3.19% CHF 6:13:00  
  Stuttgart 15.008 0.000 0.000 720 +7.35% EUR 10:52:00  
  Munich 14.035 0.000 0.000 0 +0.83% EUR 2:04:00  
  Berlin 15.115 0.000 0.000 100 +9.29% EUR 10:07:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Home Capital Group 17.74 18.50 17.64 -0.87 -4.67% 1.51M 16:00:00  
  Canopy Growth 8.460 8.810 8.350 +0.050 +0.59% 1.75M 16:00:00  
  Amazon.com 993.98 1,009.80 992.00 -9.76 -0.97% 3.39M 15:59:59  
  Aphria 5.440 5.620 5.430 -0.050 -0.91% 506.67K 15:59:00  
  Baytex Energy Corp 3.03 3.03 2.91 +0.08 +2.71% 2.12M 16:00:00  
  Apple 145.82 148.28 145.38 -0.46 -0.31% 25.69M 15:59:59  
  Tesla 377.49 386.95 373.10 -5.96 -1.55% 6.60M 15:59:59  
  Cenovus Energy Inc 9.15 9.25 9.08 -0.01 -0.11% 2.43M 16:23:00  
  AMD 14.080 14.490 13.840 -0.090 -0.64% 101.01M 15:59:59  
  Facebook 153.59 156.50 153.20 -1.48 -0.95% 18.05M 15:59:59  

Valeant Pharmaceuticals International Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

21500

Equity Type

ORD

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

Read More

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest VRX Comments

Srinath Gunaratne
Srinath Gunaratne Aug 14, 2016 4:30 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
Mohammed Ali
Mohammed Ali Jul 08, 2016 3:37 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
Jeremiah Cox
Jeremiah Cox Sep 26, 2016 17:33 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.